Skip to content
PubMed This is a summary of 62 peer-reviewed journal articles Updated
Metabolic medicine

Hyperinsulinism-hyperammonemia syndrome: A Caregiver Guide

At a Glance

HI/HA syndrome is a genetic condition in which fasting or protein-rich foods can trigger too much insulin and dangerous low blood sugar; ammonia may be mildly elevated or normal. Care combines diazoxide, individualized protein planning, glucose monitoring, and developmental follow-up.

Hyperinsulinism-hyperammonemia (HI/HA) syndrome is a rare genetic disorder that fundamentally changes how the body manages its primary fuel: sugar. This caregiver guide is designed to help parents and guardians navigate the complexities of this diagnosis.

In children with this condition, a pathogenic variant in the GLUD1 gene causes the pancreas to act like an overactive engine [1]. It inappropriately releases insulin—the hormone responsible for lowering blood sugar—particularly after exposure to protein, and sometimes during fasting. At the same time, the body’s altered nitrogen processing leads to elevated levels of ammonia. While this mild hyperammonemia is a useful diagnostic clue, it is not always present, and the primary danger of the condition is the low blood sugar [2].

The most significant challenge for families is managing the dual triggers of this condition. While most metabolic disorders cause problems only during fasting, HI/HA is unique because it is also triggered by protein [3]. An amino acid called leucine, found in common foods like eggs, meat, and dairy, acts as a direct signal to the pancreas to release insulin. This means a child’s blood sugar can crash not only after they skip a meal but also after they eat a high-protein one [4]. Because these “lows” can cause sudden seizures or loss of consciousness, many children are initially misdiagnosed with standard epilepsy before the true metabolic cause is discovered [1].

The primary danger in HI/HA is hypoglycemia (low blood sugar), which deprives the brain of the energy it needs to function [5]. Fortunately, most children respond well to a first-line medication called diazoxide, which helps “quiet” the insulin-producing cells [6]. Management is further supported by working with specialized dietitians to individualize protein intake, ensuring the child gets the nutrition they need for growth while minimizing dangerous blood sugar drops [1].

Living with HI/HA requires a long-term commitment to monitoring and proactive care under the supervision of a metabolic specialist. Beyond stabilizing blood sugar, families and medical teams must focus on the “whole child,” including regular assessments of learning, speech, and motor skills [7]. While the diagnosis can be overwhelming, a structured approach—combining the right medication, dietary adjustments, and developmental support—provides a clear framework for protecting a child’s health and helping them thrive [8].

Common questions in this guide

What causes hyperinsulinism-hyperammonemia syndrome?
A harmful change in the GLUD1 gene alters how insulin-producing cells respond to protein and fasting. The pancreas may release too much insulin, causing low blood sugar, while ammonia levels may be mildly elevated.
Why can protein trigger low blood sugar in HI/HA syndrome?
Leucine, an amino acid found in foods such as meat, eggs, and dairy, can signal the pancreas to release insulin in children with HI/HA syndrome. This can cause blood sugar to drop after a protein-rich meal, even when the child has eaten.
What is the main health risk of HI/HA syndrome?
Low blood sugar is the main immediate danger because the brain needs glucose to function. Severe episodes can cause seizures or loss of consciousness, so families need an individualized monitoring and response plan from their care team.
How is HI/HA syndrome treated and managed?
Most children respond well to diazoxide, which reduces inappropriate insulin release. Care also includes individualized protein planning with a specialized dietitian, blood sugar monitoring, and follow-up with a metabolic specialist.
Can HI/HA syndrome be mistaken for epilepsy?
Yes. Seizures or episodes caused by low blood sugar can resemble epilepsy, and some children are initially misdiagnosed. A neurologist and metabolic team can help determine whether episodes are related to glucose levels or need additional evaluation.
Why does a child with HI/HA syndrome need developmental follow-up?
Regular checks of learning, speech, and motor skills help the care team identify support needs early while blood sugar is being managed. The child's clinicians can set the follow-up schedule and coordinate school or developmental services.

Get notified when new evidence is published on Hyperinsulinism-hyperammonemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.

    De Los Santos-La Torre MA, Del Águila-Villar CM, Lu-de Lama LR, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(2)):207-211 doi:10.1515/jpem-2022-0490.

    PMID: 36476334
  2. 2

    Hyperinsulinism-hyperammonemia Syndrome in an Infant with Seizures.

    Strajnar A, Tansek MZ, Podkrajsek KT, et al.

    Balkan journal of medical genetics : BJMG 2018; (21(1)):77-81 doi:10.2478/bjmg-2018-0014.

    PMID: 30425915
  3. 3

    Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.

    Roy K, Satapathy AK, Houhton JAL, et al.

    Indian journal of pediatrics 2019; (86(11)):1051-1053 doi:10.1007/s12098-019-02980-x.

    PMID: 31119523
  4. 4

    Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.

    Grimaldi M, Karaca M, Latini L, et al.

    Human molecular genetics 2017; (26(18)):3453-3465 doi:10.1093/hmg/ddx213.

    PMID: 28911206
  5. 5

    Reverse Phenotyping: Addressing Refractory Seizures From an Endocrine Perspective.

    Sherin S, Soodhana D, Mohanlal S, Pachat D

    Cureus 2024; (16(12)):e75146 doi:10.7759/cureus.75146.

    PMID: 39759686
  6. 6

    Clinical and Molecular Spectrum of Glutamate Dehydrogenase Gene Defects in 26 Chinese Congenital Hyperinsulinemia Patients.

    Su C, Liang XJ, Li WJ, et al.

    Journal of diabetes research 2018; (2018()):2802540 doi:10.1155/2018/2802540.

    PMID: 30306091
  7. 7

    Spectrum of neuro-developmental disorders in children with congenital hyperinsulinism due to activating mutations in GLUD1.

    Aftab S, Gubaeva D, Houghton JAL, et al.

    Endocrine connections 2023; (12(4)).

    PMID: 35951311
  8. 8

    Congenital Hyperinsulinism International: A Community Focused on Improving the Lives of People Living With Congenital Hyperinsulinism.

    Raskin J, Pasquini TLS, Bose S, et al.

    Frontiers in endocrinology 2022; (13()):886552 doi:10.3389/fendo.2022.886552.

    PMID: 35573986

This caregiver guide is for informational purposes only and does not constitute medical advice. Your child's metabolic specialist and care team should guide decisions about diazoxide, protein intake, blood sugar monitoring, and developmental follow-up.